1274 related articles for article (PubMed ID: 31880875)
1. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature.
Arastehfar A; Daneshnia F; Salehi MR; Zarrinfar H; Khodavaisy S; Haas PJ; Roudbary M; Najafzadeh MJ; Zomorodian K; Charsizadeh A; Brouwer C; Pan W; Hagen F; Boekhout T
J Med Microbiol; 2019 May; 68(5):770-777. PubMed ID: 30924763
[TBL] [Abstract][Full Text] [Related]
3. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
[TBL] [Abstract][Full Text] [Related]
5. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
Dagi HT; Findik D; Senkeles C; Arslan U
Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
[TBL] [Abstract][Full Text] [Related]
6. Candida glabrata species complex prevalence and antifungal susceptibility testing in a culture collection: First description of Candida nivariensis in Argentina.
Morales-López SE; Taverna CG; Bosco-Borgeat ME; Maldonado I; Vivot W; Szusz W; Garcia-Effron G; Córdoba SB
Mycopathologia; 2016 Dec; 181(11-12):871-878. PubMed ID: 27681573
[TBL] [Abstract][Full Text] [Related]
7. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
Mario DA; Denardi LB; Bandeira LA; Antunes MS; Santurio JM; Severo LC; Alves SH
Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843
[TBL] [Abstract][Full Text] [Related]
8. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
9. Occurrence and characterization of Candida nivariensis from a culture collection of Candida glabrata clinical isolates in Malaysia.
Tay ST; Lotfalikhani A; Sabet NS; Ponnampalavanar S; Sulaiman S; Na SL; Ng KP
Mycopathologia; 2014 Oct; 178(3-4):307-14. PubMed ID: 25022264
[TBL] [Abstract][Full Text] [Related]
10. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibility profile of invasive
Memon S; Farooqi J; Zafar U; Naqvi SF; Zafar A; Jabeen K
J Med Microbiol; 2021 Dec; 70(12):. PubMed ID: 34878377
[No Abstract] [Full Text] [Related]
12. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
Schmalreck AF; Willinger B; Haase G; Blum G; Lass-Flörl C; Fegeler W; Becker K;
Mycoses; 2012 May; 55(3):e124-37. PubMed ID: 22233267
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
[TBL] [Abstract][Full Text] [Related]
14. Fluconazole Resistance in Isolates of Uncommon Pathogenic Yeast Species from the United Kingdom.
Borman AM; Muller J; Walsh-Quantick J; Szekely A; Patterson Z; Palmer MD; Fraser M; Johnson EM
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182537
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and Antifungal Susceptibility of
Badiee P; Boekhout T; Haddadi P; Mohammadi R; Ghadimi-Moghadam A; Soltani J; Zarei Mahmoudabadi A; Ayatollahi Mousavi SA; Najafzadeh MJ; Diba K; Salimi-Khorashad AR; Amin Shahidi M; Ghasemi F; Jafarian H
Microbiol Spectr; 2022 Dec; 10(6):e0245322. PubMed ID: 36445122
[TBL] [Abstract][Full Text] [Related]
16. Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents.
Borman AM; Petch R; Linton CJ; Palmer MD; Bridge PD; Johnson EM
J Clin Microbiol; 2008 Mar; 46(3):933-8. PubMed ID: 18199788
[TBL] [Abstract][Full Text] [Related]
17.
Zhang W; Zhan M; Wang N; Fan J; Han X; Li C; Liu J; Li J; Hou Y; Wang X; Zhang Z
J Med Microbiol; 2023 Mar; 72(3):. PubMed ID: 36920840
[No Abstract] [Full Text] [Related]
18. Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains.
Denardi LB; Keller JT; Oliveira V; Mario DAN; Santurio JM; Alves SH
Mycopathologia; 2017 Oct; 182(9-10):819-828. PubMed ID: 28493006
[TBL] [Abstract][Full Text] [Related]
19. Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection.
Bishop JA; Chase N; Magill SS; Kurtzman CP; Fiandaca MJ; Merz WG
J Clin Microbiol; 2008 Feb; 46(2):443-6. PubMed ID: 18077641
[TBL] [Abstract][Full Text] [Related]
20. Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center.
Marcos-Zambrano LJ; Escribano P; Sánchez C; Muñoz P; Bouza E; Guinea J
Antimicrob Agents Chemother; 2014 Aug; 58(8):4565-72. PubMed ID: 24867979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]